Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Laimer
Christine Prodinger

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 11, 2020
EB (epidermolysis bullosa)-House Austria: Pioneering work for the care of patients with rare diseasesChristine Prodinger, Martin Laimer, Johann W Bauer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 28, 2015
[Austrian and European initiatives in the field of rare diseases perspectives for a "marginal group" of many millions of patients]Martin Laimer, Christine Prodinger, Verena Ahlgrimm-Siess, et al.
Wiener Klinische Wochenschrift|December 3, 2016
Epidermolysis bullosa House Austria and Epidermolysis bullosa clinical network : Example of a centre of expertise implemented in a European reference network to face the burden of a rare diseaseMartin Laimer, Gabriela Pohla-Gubo, Anja Diem, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2017
Noninvasive RCM for Differentiation of Melanotic Macules From Melanocytic Lesions-Blinded Evaluation of a Series of 42 Pigmented MaculesMartin Laimer, Edith Arzberger, Clara-Anna Kirchner, et al.
BMC Pregnancy and Childbirth|December 16, 2025
Patient-reported outcomes during pregnancy and delivery in epidermolysis bullosaAnna Zott, Anja Diem, Christine Prodinger, et al.
Dermatology and Therapy|June 10, 2021
Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis BullosaTobias Welponer, Christine Prodinger, Josefina Pinon-Hofbauer, et al.
Orphanet Journal of Rare Diseases|July 12, 2020
Profiling trial burden and patients' attitudes to improve clinical research in epidermolysis bullosaChristine Prodinger, Anja Diem, Katherina Ude-Schoder, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 7, 2025
Complicated and deep bacterial skin and soft tissue infectionsChristine Prodinger, Arno Lechner, Arno Hintersteininger, et al.
The Journal of Dermatological Treatment|July 28, 2024
Systematic review on antipruritic therapies for patients with Epidermolysis bullosaTobias Welponer, Christian Puttinger, Eva W H Korte, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 18, 2022
Martin Laimer
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 11, 2020
EB (epidermolysis bullosa)-House Austria: Pioneering work for the care of patients with rare diseasesChristine Prodinger, Martin Laimer, Johann W Bauer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 28, 2015
[Austrian and European initiatives in the field of rare diseases perspectives for a "marginal group" of many millions of patients]Martin Laimer, Christine Prodinger, Verena Ahlgrimm-Siess, et al.
Wiener Klinische Wochenschrift|December 3, 2016
Epidermolysis bullosa House Austria and Epidermolysis bullosa clinical network : Example of a centre of expertise implemented in a European reference network to face the burden of a rare diseaseMartin Laimer, Gabriela Pohla-Gubo, Anja Diem, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2017
Noninvasive RCM for Differentiation of Melanotic Macules From Melanocytic Lesions-Blinded Evaluation of a Series of 42 Pigmented MaculesMartin Laimer, Edith Arzberger, Clara-Anna Kirchner, et al.
BMC Pregnancy and Childbirth|December 16, 2025
Patient-reported outcomes during pregnancy and delivery in epidermolysis bullosaAnna Zott, Anja Diem, Christine Prodinger, et al.
Dermatology and Therapy|June 10, 2021
Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis BullosaTobias Welponer, Christine Prodinger, Josefina Pinon-Hofbauer, et al.
Orphanet Journal of Rare Diseases|July 12, 2020
Profiling trial burden and patients' attitudes to improve clinical research in epidermolysis bullosaChristine Prodinger, Anja Diem, Katherina Ude-Schoder, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 7, 2025
Complicated and deep bacterial skin and soft tissue infectionsChristine Prodinger, Arno Lechner, Arno Hintersteininger, et al.
The Journal of Dermatological Treatment|July 28, 2024
Systematic review on antipruritic therapies for patients with Epidermolysis bullosaTobias Welponer, Christian Puttinger, Eva W H Korte, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 18, 2022
Martin Laimer
Pageof 12